Table 2.
Clinical characteristics of SGA and control cases who underwent miRNA analysis using exosomes.
| Total (n = 16) | SGA | AGA | p-Value | |
|---|---|---|---|---|
| SGA-nCU | SGA-CU | |||
| n (%) | 6 (37.5) | 5 (31.25) | 5 (31.25) | - |
| Boys/girls | 3/3 | 2/3 | 2/3 | - |
| GA (weeks) | 38.60 ± 1.36 | 38.20 ± 1.09 | 39.20 ± 1.30 | 0.353 |
| Birth weight (kg) | 2.39 ± 0.24 | 2.06 ± 0.23 | 3.47 ± 0.29 | 0.003 |
| CA (year) | 4.44 ± 0.31 | 5.93 ± 0.77 | 5.87 ± 1.06 | 0.018 |
| Height (cm) | 96.66 ± 1.89 | 111.66 ± 3.78 | 117.58 ± 7.92 | 0.004 |
| Height SDS | –2.10 ± 0.27 | –0.61 ± 0.39 | 0.69 ± 0.82 | 0.001 |
| Weight (kg) | 14.16 ± 1.74 | 17.96 ± 1.88 | 25.50 ± 7.42 | 0.003 |
| Weight SDS | –2.06 ± 1.14 | –1.17 ± 0.67 | 1.19 ± 1.15 | 0.006 |
| BMI SDS | –0.62 ± 1.21 | –1.17 ± 0.85 | 1.12 ± 1.52 | 0.025 |
The Kruskal–Wallis test was performed. CU, catch-up growth; GA, gestational age; BW, birthweight; CA, chronological age; BMI, body mass index; SDS, standard deviation score.